Xenon Pharmaceuticals Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
50.50
|
|
Average Rating
|
4.69
|
|
# Strong Buys
|
11
|
|
# Buys
|
5
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.52
|
-0.57
|
-0.05
|
-9.62%
|
|
2022-06-30
|
-0.48
|
-0.55
|
-0.07
|
-14.58%
|
|
2022-03-31
|
-0.41
|
-0.35
|
0.06
|
14.63%
|
|
2021-12-31
|
-0.37
|
-0.48
|
-0.11
|
-29.73%
|
|
2021-09-30
|
-0.38
|
-0.36
|
0.02
|
5.26%
|
|
2021-06-30
|
-0.48
|
-0.51
|
-0.03
|
-6.25%
|
|
2021-03-31
|
-0.43
|
-0.42
|
0.01
|
2.33%
|
|
2020-12-31
|
-0.40
|
-0.34
|
0.06
|
15.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.47
|
|
2021-12-31
|
-1.77
|
|
2020-12-31
|
-0.81
|
|
2019-12-31
|
-1.54
|
|
2018-12-31
|
-1.58
|
|
2017-12-31
|
-1.71
|
|
2016-12-31
|
-1.48
|
|
2015-12-31
|
-0.76
|
|
2014-12-31
|
4.23
|